ArticleIntractable & rare diseases research2021

Rituximab use for refractory anti-HMGCR immune-mediated necrotizing myopathy: A case report.

Sonia Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.